Aims: Many inoperable patients with severe aortic stenosis (AS) are not immediately eligible for transcatheter aortic valve implantation (TAVI). We evaluated the role of percutaneous balloon aortic valvuloplasty (BAV) in this setting. Methods and results: Among 210 consecutive patients referred to our institution for BAV, we identified three groups: immediately eligible for TAVI (n=65, 31%), excluded from TAVI (n=67, 32%), BAV as a bridge to TAVI (n=78, 37%). This last group comprised patients with low left ventricular ejection fraction, frailty or enfeebled status, symptoms of uncertain origin, critical conditions, moderate-to-severe mitral valve regurgitation, need of major non-cardiac surgery. Outpatient clinic visit and echocardiography were performed around one month after BAV to decide the final therapeutic strategy. Mean age was 81±8 years and the vast majority of patients had comorbidities and high-risk features. The incidence of periprocedural adverse events was 6.4%: 5.1% death (four patients: one procedural complication, three, natural disease progression), 1.3% minor stroke. After BAV, 46% of these patients were deemed eligible for TAVI, and 28% for cardiac surgery. Patients who underwent TAVI after bridge BAV showed 94% 30-day survival. Conclusions: BAV is a safe and effective tool to bridge selected patients to TAVI when indications are not obvious

Saia F, Marrozzini C, Moretti C, Ciuca C, Taglieri N, Bordoni B, et al. (2011). The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EUROINTERVENTION, 30, 723-729 [10.4244/EIJV7I6A115].

The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation.

SAIA, FRANCESCO;MORETTI, CAROLINA;CIUCA, CRISTINA;TAGLIERI, NEVIO;BORDONI, BARBARA;DALL'ARA, GIANNI;ALESSI, LAURA;BACCHI REGGIANI, MARIA LETIZIA;BRANZI, ANGELO;MARZOCCHI, ANTONIO
2011

Abstract

Aims: Many inoperable patients with severe aortic stenosis (AS) are not immediately eligible for transcatheter aortic valve implantation (TAVI). We evaluated the role of percutaneous balloon aortic valvuloplasty (BAV) in this setting. Methods and results: Among 210 consecutive patients referred to our institution for BAV, we identified three groups: immediately eligible for TAVI (n=65, 31%), excluded from TAVI (n=67, 32%), BAV as a bridge to TAVI (n=78, 37%). This last group comprised patients with low left ventricular ejection fraction, frailty or enfeebled status, symptoms of uncertain origin, critical conditions, moderate-to-severe mitral valve regurgitation, need of major non-cardiac surgery. Outpatient clinic visit and echocardiography were performed around one month after BAV to decide the final therapeutic strategy. Mean age was 81±8 years and the vast majority of patients had comorbidities and high-risk features. The incidence of periprocedural adverse events was 6.4%: 5.1% death (four patients: one procedural complication, three, natural disease progression), 1.3% minor stroke. After BAV, 46% of these patients were deemed eligible for TAVI, and 28% for cardiac surgery. Patients who underwent TAVI after bridge BAV showed 94% 30-day survival. Conclusions: BAV is a safe and effective tool to bridge selected patients to TAVI when indications are not obvious
2011
Saia F, Marrozzini C, Moretti C, Ciuca C, Taglieri N, Bordoni B, et al. (2011). The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EUROINTERVENTION, 30, 723-729 [10.4244/EIJV7I6A115].
Saia F; Marrozzini C; Moretti C; Ciuca C; Taglieri N; Bordoni B; Dall'ara G; Alessi L; Lanzillotti V; Bacchi-Reggiani ML; Branzi A; Marzocchi A....espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/107096
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 56
social impact